Legacy Education Q3 Earnings Show Strong Growth, But Risks Persist

What happened

Legacy Education reported higher Q3 revenue and earnings, driven by robust demand for healthcare workforce training in nursing, imaging, and surgical technology. The company continues to benefit from strong enrollment momentum, with new student starts up 31.6% in Q1 FY26 and total student population up 37.7%. However, the DeepValue report flags ongoing structural risks: heavy reliance on Title IV funding, California concentration, and regulatory overhang in the for-profit education sector. Despite mid-teens EBITDA margins and a net-cash balance sheet, free cash flow remains volatile and substantial lease obligations constrain financial flexibility. The stock trades at a modest ~6-7x earnings multiple, reflecting investor caution around these persistent headwinds.

Implication

Legacy offers leveraged exposure to healthcare education demand at a discounted multiple, but position sizing should be small and contingent on regulatory clarity and consistent cash conversion. Upgrade to BUY only if Title IV and accreditation risks recede.

Thesis delta

The Q3 earnings beat reinforces near-term enrollment and margin momentum, aligning with the DeepValue report's positive operational trends. However, the core thesis remains unchanged: the stock is a POSSIBLE BUY for risk-tolerant investors, with watch items on regulatory developments and cash flow consistency remaining paramount. No upgrade warranted yet, as structural risks are unchanged.